Vildagliptin Impurity 15 - Request Quote
Vildagliptin Impurity 15
| SZ CAT No: | SZ-V008045 |
| CAS No | NA |
| Mol.F. | C22H34N2O3 |
| Mol.Wt. | 374.5 |
| Inv. Status | In Stock |
| Shipping Condition | Room Temperature |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Vildagliptin Impurity 15 is chemically N-((1r,3S,5R,7S)-3-Hydroxyadamantan-1-yl)-2-(((1r,3S,5R,7S)-3-hydroxyadamantan-1-yl)amino)acetamide. Vildagliptin Impurity 15 is supplied with detailed characterization data compliant with regulatory guideline. Vildagliptin Impurity 15 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Vildagliptin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Vildagliptin Impurity 15
Purchase Vildagliptin Impurity 15
Vildagliptin Impurity 15 suppliers
Vildagliptin Impurity 15 manufacturers
Vildagliptin Impurity 15 price
Order Vildagliptin Impurity 15
Enquire Vildagliptin Impurity 15
Vildagliptin Impurity 15 cost
Vildagliptin Impurity 15 Supplier
Vildagliptin Impurity 15 Distributor
Vildagliptin Impurity 15 for Method Validation
Vildagliptin Reference Standard
Vildagliptin Impurity 15 for ANDA Filing
Vildagliptin Impurity 15 for Forced Degradation Studies
Vildagliptin Impurity 15 Identification Standards
Vildagliptin Impurity 15 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


